Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
icovamenib (BMF-219)
i
Other names:
BMF-219
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(10)
News
Trials
Company:
Biomea Fusion
Drug class:
Menin-MLL inhibitor
Related drugs:
‹
revumenib (18)
ziftomenib (13)
VTP-50469 (5)
MI-503 (4)
JNJ-6617 (4)
DS-1594 (3)
D0060-319 (1)
MI-2 (1)
DSP-5336 (1)
revumenib (18)
ziftomenib (13)
VTP-50469 (5)
MI-503 (4)
JNJ-6617 (4)
DS-1594 (3)
D0060-319 (1)
MI-2 (1)
DSP-5336 (1)
›
Associations
(10)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12V
Pancreatic Cancer
KRAS G12V
Pancreatic Cancer
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
KRAS G12D
Non Small Cell Lung Cancer
KRAS G12D
Non Small Cell Lung Cancer
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
KRAS G12C
Colorectal Cancer
KRAS G12C
Colorectal Cancer
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
KRAS G12C
Lung Cancer
KRAS G12C
Lung Cancer
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
Chr del(13q)
Chronic Lymphocytic Leukemia
Chr del(13q)
Chronic Lymphocytic Leukemia
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
NOTCH1 mutation
Chronic Lymphocytic Leukemia
NOTCH1 mutation
Chronic Lymphocytic Leukemia
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
NRAS mutation
Multiple Myeloma
NRAS mutation
Multiple Myeloma
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
KRAS mutation
Multiple Myeloma
KRAS mutation
Multiple Myeloma
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
TP53 mutation
Multiple Myeloma
TP53 mutation
Multiple Myeloma
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.